Structured Higher Protein Meal Replacement Plans for Weight Loss and Metabolic Health: A Qualitative Narrative Evidence Review of Medifast Interventions

Excess body weight and impaired metabolic health increase chronic disease risk, necessitating effective weight management strategies. Commercial weight loss programs are widely used, but impact on body composition and cardiometabolic markers requires evaluation. The objective of this narrative review was to assess the efficacy of Medifast’s structured higher protein meal replacement plans with comprehensive lifestyle intervention. In this narrative qualitative evidence review, publications (2010–2025) utilizing Medifast meal plans (800–1000/80–120; 1100–1300/120–150; 1300–1500/140–170 kcal/g protein/day) as a weight loss intervention were identified . Two reviewers extracted data on study design, population characteristics, interventions, outcomes and corresponding results, as reported in the publications; a third verified accuracy. Seventeen publications representing nine unique randomized controlled trials (RCTs) and additional secondary analyses and chart reviews were included (n=20-816; 4-26 weeks duration). Participants were adults living with overweight/obesity, including older adults and those with coexisting conditions (e.g., post-prostatectomy, post-ischemic stroke). Thirteen of 14 studies reported clinically meaningful weight loss (≥5%) with 7 reporting ≥10%. Total fat mass (FM) was significantly reduced in all reporting studies (3.2–11.0 kg; 11/11 studies; p <0.05) and visceral FM in 4/5 studies (varied reporting; p <0.05), while lean mass was preserved within ≤6% baseline (13/13 studies). Favorable decreases occurred in blood pressure (3.2-19.6 mmHg SBP; 1.6-9.0 mmHg DBP); significance varied. Outcomes for lipid and glycemic markers were mixed; significant between-group improvements ( p <0.05) were observed for total and LDL cholesterol (2/5 RCTs), fasting insulin (3/4 RCTs), and A1c (1/1 RCT). Medifast’s structured, higher protein meal replacement plans with comprehensive lifestyle interventions yield clinically meaningful short-term weight loss and favorable body composition changes; cardiometabolic outcomes vary. While long-term durability data are needed, clinicians may consider these plans as options for the dietary foundation within the obesity care framework, tailored to individual patient needs.